In Silico Approaches for the Identification of Novel Inhibitors against Breast Cancer Up-Regulated Protein
| المصدر: | المجلة العلمية لجامعة الملك فيصل - العلوم الأساسية والتطبيقية |
|---|---|
| الناشر: | جامعة الملك فيصل |
| المؤلف الرئيسي: | Aloufi, Bandar Hamad (Author) |
| مؤلفين آخرين: | Alshmmari, Ahmed Mohajja (Co-Author) |
| المجلد/العدد: | مج23, ع1 |
| محكمة: | نعم |
| الدولة: |
السعودية |
| التاريخ الميلادي: |
2022
|
| الصفحات: | 100 - 105 |
| ISSN: |
1658-0311 |
| رقم MD: | 1287999 |
| نوع المحتوى: | بحوث ومقالات |
| اللغة: | الإنجليزية |
| قواعد المعلومات: | science |
| مواضيع: | |
| كلمات المؤلف المفتاحية: |
Bioinformatics | Docking | Drug Candidates | Molecular Dynamic Simulation | Phytochemicals | Protein Data Bank
|
| رابط المحتوى: |
| المستخلص: |
" Breast cancer is a type of cancer that develops in the breast tissues. When some breast cells begin to grow abnormally, breast cancer develops. These cells grow and divide at a faster rate than healthy cells and continue to grow, generating a lump or mass. Cancer cells in the breast may spread to lymph nodes or other places of the body. The hormone estrogen encourages cancer growth when it binds to the receptor of the targeted protein. The purpose of this study is the rational screening of a 15,000 phytochemicals library against the estrogen receptor alpha protein. The library was employed for molecular docking to find the binding affinities and simulation analysis of the top-selected compounds. The top four compounds, Mangostenone E, Exiguaflavanone M, Sanggenon A, and Flaccidine were identified as direct inhibitors of estrogen receptors as evident from their high binding affinity and occupancy of specific binding sites. Mangostenone E was the leading phytochemical that showed a high docking score-15.97 (kcal/mol) - and bonding interaction at the active site of Mangostenone E. Leading phytochemicals were subjected to analysis for drug-like properties that further reinforced their validation. Potential molecules identified in this study can be considered lead drugs for the treatment of breast cancer." |
|---|---|
| ISSN: |
1658-0311 |
عناصر مشابهة
-
Molecular Study On Part Of Exon 1 And Exon 2 Of Estrogen Receptor Alpha Of Iraqi Woman With Breast Cancer
بواسطة: Abd Alhassan, Hadeel منشور: (2019) -
THE INFLUENCE OF DIET ON ESTROGEN RECEPTOR STATUS IN BLACK AND WHITE BREAST CANCER PATIENTS
بواسطة: Aba Alkhail, Bahaa Abd Alrahman منشور: (1986) -
In Vitro Evaluation of Potential Therapeutic Benefits of Selective Estrogen Receptor Modulators "SERMs" for Lung Cancer Treatment
بواسطة: الصوص، لينا عدنان منشور: (2020) -
Predictability of the Expression of ER, PR Receptors, HER2 Marker by the Coloration with of IV Collagen Expression and AgNORs in Breast Carcinoma among Iraqi Women in Thi-Qar Providence: Immunoh istochemical Study
بواسطة: Al Ezerjawy, Doha K. Najam منشور: (2016) -
Regulation of Desmosomal Proteins by Dihydrotestosterone in the Molecular Apocrine Mda-Mb-453 Breast Cancer Cell Line
بواسطة: مصطفى، شهد أرقم حسين منشور: (2019)
